Talecris Biotherapeutics Receives FDA Approval for Prolastin-C
Links shared publicly online about this topic.
- 1,665total visits
Talecris Biotherapeutics Receives FDA Approval for Prolastin-C
View full resource at drugs.com
Tags: FDA
Most Recently Shared on October 19, 2009 at 11:25 pm By:
Talecris Biotherapeutics Receives FDA Approval for Prolastin-C - http://bit.ly/5wST9
Talecris Biotherapeutics Receives FDA Approval for Gamunex-C
drugs.com — “Gamunex-C (immune globulin subcutaneous (human)) is used to treat primary immunodeficiency. Includes Gamunex-C side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 17, 2010 at 11:49 pm By:
Talecris Biotherapeutics Receives FDA Approval for Gamunex-C - http://bit.ly/drm0FC
Talecris Biotherapeutics Receives FDA Approval For Gamunex®-C
medicalnewstoday.com — “Talecris Biotherapeutics (Nasdaq: TLCR) announced that the U.S. Food and Drug Administration (FDA) approved Gamunex®-C (Immune Globulin Injection [Human], 10% Caprylate/Chromatography Purifie” View full resource at medicalnewstoday.com
Most Recently Shared on October 15, 2010 at 4:05 pm By:
MNT Pharma News Pharma and Health News
Talecris Biotherapeutics Receives FDA Approval For Gamunex®-C http://mnt.to/3Lgv #pharma #pharmaceutical
Concentrated Prolastin-C approved for alpha1-antitrypsin (AAT) deficiency - MPR
empr.com — “The FDA has approved Prolastin-C (alpha1-proteinase inhibitor [human], from Talecris Biotherapeutics), a more concentrated formulation of Prolastin, for the treatment of alpha1-antitrypsin (AAT) deficiency.” View full resource at empr.com
Most Recently Shared on November 15, 2009 at 9:15 pm By:
Concentrated Prolastin-C approved for alpha1-antitrypsin (AAT) deficiency ... http://cli.gs/S678E
Advertisement
